HUMAN TECHNOLOGY Co., Ltd (KOSDAQ:175140)
South Korea · Delayed Price · Currency is KRW 3,995.00
0.00 (0.00%)
At close: Feb 13, 2026
HUMAN TECHNOLOGY Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 49,307 | 42,683 | 38,503 | 35,537 | 46,673 | 43,506 |
Other Revenue | 0 | - | -0 | -0 | -0 | - |
| 49,307 | 42,683 | 38,503 | 35,537 | 46,673 | 43,506 | |
Revenue Growth (YoY) | 3.38% | 10.86% | 8.35% | -23.86% | 7.28% | -42.17% |
Cost of Revenue | 42,882 | 34,845 | 37,926 | 32,294 | 39,762 | 41,199 |
Gross Profit | 6,425 | 7,838 | 576.99 | 3,243 | 6,911 | 2,307 |
Selling, General & Admin | 13,939 | 12,578 | 8,291 | 5,619 | 7,008 | 6,914 |
Research & Development | 1,368 | 435.63 | 1,182 | 2,246 | 2,048 | 2,405 |
Amortization of Goodwill & Intangibles | 828 | 102.1 | 74.21 | 42.22 | 62.61 | 1,222 |
Other Operating Expenses | 86.82 | 86.82 | 37.61 | 33.67 | 40.39 | 30.71 |
Operating Expenses | 20,022 | 13,547 | 11,117 | 10,314 | 9,853 | 10,886 |
Operating Income | -13,598 | -5,709 | -10,540 | -7,071 | -2,942 | -8,579 |
Interest Expense | -945.43 | -1,115 | -355.94 | -1,187 | -804.48 | -1,855 |
Interest & Investment Income | 725.38 | 1,115 | 595.38 | 238.39 | 93.57 | 132.67 |
Earnings From Equity Investments | 677.99 | 1,392 | 3,802 | -1,030 | -742.52 | -1,075 |
Currency Exchange Gain (Loss) | 106.54 | 364.02 | 75.86 | -319.27 | 26 | -516.34 |
Other Non Operating Income (Expenses) | -6.78 | -83.64 | 287.53 | -1,333 | 139.2 | 2,017 |
EBT Excluding Unusual Items | -13,040 | -4,037 | -6,135 | -10,702 | -4,230 | -9,876 |
Gain (Loss) on Sale of Investments | 260.85 | -58.48 | -610.26 | 709.66 | -722.85 | 1,381 |
Gain (Loss) on Sale of Assets | -278.84 | -525.15 | -67.4 | -223.51 | -58.6 | 1.86 |
Asset Writedown | -12,086 | -11,567 | -8,065 | - | -586.64 | -2,429 |
Other Unusual Items | 23.47 | 4.49 | 40.2 | -35.05 | 91.84 | 137.98 |
Pretax Income | -25,121 | -16,184 | -14,838 | -10,251 | -5,506 | -10,784 |
Income Tax Expense | -120.49 | -3.39 | -1.69 | - | 653.61 | 583.65 |
Earnings From Continuing Operations | -25,000 | -16,180 | -14,836 | -10,251 | -6,160 | -11,367 |
Earnings From Discontinued Operations | - | - | - | - | - | 418 |
Net Income to Company | -25,000 | -16,180 | -14,836 | -10,251 | -6,160 | -10,949 |
Minority Interest in Earnings | 124.92 | 203.85 | 666.26 | - | - | 15.39 |
Net Income | -24,875 | -15,976 | -14,170 | -10,251 | -6,160 | -10,934 |
Net Income to Common | -24,875 | -15,976 | -14,170 | -10,251 | -6,160 | -10,934 |
Shares Outstanding (Basic) | 24 | 20 | 15 | 8 | 5 | 4 |
Shares Outstanding (Diluted) | 24 | 20 | 15 | 8 | 5 | 4 |
Shares Change (YoY) | 31.71% | 31.18% | 86.94% | 60.23% | 40.44% | 0.62% |
EPS (Basic) | -1035.22 | -791.43 | -920.84 | -1245.31 | -1198.95 | -2988.81 |
EPS (Diluted) | -1035.22 | -791.43 | -921.00 | -1245.31 | -1199.00 | -2992.74 |
Free Cash Flow | -12,698 | -2,180 | -15,670 | -18,297 | 11,099 | 7,676 |
Free Cash Flow Per Share | -528.45 | -107.97 | -1018.29 | -2222.73 | 2160.29 | 2098.15 |
Gross Margin | 13.03% | 18.36% | 1.50% | 9.12% | 14.81% | 5.30% |
Operating Margin | -27.58% | -13.38% | -27.38% | -19.90% | -6.30% | -19.72% |
Profit Margin | -50.45% | -37.43% | -36.80% | -28.85% | -13.20% | -25.13% |
Free Cash Flow Margin | -25.75% | -5.11% | -40.70% | -51.49% | 23.78% | 17.64% |
EBITDA | -11,006 | -4,029 | -9,656 | -6,152 | -1,073 | -5,579 |
EBITDA Margin | -22.32% | -9.44% | -25.08% | -17.31% | -2.30% | -12.82% |
D&A For EBITDA | 2,592 | 1,680 | 884.49 | 919.67 | 1,869 | 3,000 |
EBIT | -13,598 | -5,709 | -10,540 | -7,071 | -2,942 | -8,579 |
EBIT Margin | -27.58% | -13.38% | -27.38% | -19.90% | -6.30% | -19.72% |
Advertising Expenses | - | 35.37 | 39.78 | 0.16 | 16.49 | 9.98 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.